Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Daily CryptoCann™ Report: Top economist thinks regulation will be the end of Bitcoin; WeedMD inks supply deal in British Columbia

Joseph Stiglitz, former chief economist of the World Bank, sees heavy regulation ahead for Bitcoin
Daily CryptoCann™ Report: Top economist thinks regulation will be the end of Bitcoin; WeedMD inks supply deal in British Columbia
As cryptocurrency continues to grow, it will be regulated to the point of being useless, Stiglitz says

The Crypto Report

Spain's Banco Santander SA (NYSE:SAN) is putting together a blockchain research team to explore the potential of applying the technology to securities trading.

Known as the “Digital Investment Banking” team, the group will look into the use of tokenized securities in debt capital markets, derivatives and other areas, as per a press release.

“The wave of digitalization that is occurring in the financial industry is accelerating. Our clients expect this to result in better solutions, lower costs and new categories of products and services that enable them to access capital markets more efficiently than ever before,” said José M. Linares, the bank’s head of corporate & investment banking in a statement.

Shares of the Madrid-based bank were up slightly to US$5.47 in Thursday afternoon trading.

READ: Daily CryptoCann™ Report: Walmart files a patent for blockchain delivery system; Michigan approves new conditions for its medicinal marijuana program

Back in the States, Nobel prize-winning economist Joseph Stiglitz had harsh words for cryptocurrency, forecasting heavy regulations going forward.

"If you open up a hole like bitcoin, then all the nefarious activity will go through that hole, and no government can allow that,” said Stiglitz in an interview with the Financial News.

Stiglitz, the former chief economist of the World Bank, predicts that as cryptocurrency continues to grow, it will be regulated to the point of being “useless.”

The price of Bitcoin is down slightly to US$6,192.18.

The Cann Report

WeedMD Inc (CVE:WMD) is continuing to expand alongside the Canadian cannabis market.

The Ontario-based cannabis company signed a supply deal with the British Columbia Liquor Distribution Brand.

"B.C. is widely recognized for having one of the most mature and developed cannabis consumer markets in Canada," said CEO Keith Merker.

The company recently inked deals with the Alberta Gaming, Liquor and Cannabis Commission as well as Shoppers Drug Mart, one of Canada’s largest pharmacy chains.

Shares of WeedMD were down slightly to C$1.70.

READ: WeedMD shares put on growth spurt as it inks new pot supply deal with British Columbia

In other news up North, medical marijuana company Sunniva Inc (CSE:SNN) is planning to spin off its Canadian assets into a separate Canadian asset to list on the Toronto Stock Exchange and the Nasdaq.

The multinational firm’s proposal includes Sunniva Medical and Natural Health Services, as per a press release.

Sunniva Medical is currently building a 740,000 square foot greenhouse facility in British Columbia. Canopy Growth Corp (NYSE:CGC) will buy 45% of its annual production capacity.

Natural Health Services operates a network of seven medical cannabis clinics.

Shares of Vancouver-based Sunniva were down slightly to C$7.89.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

August 30 2018

Related Articles

Kaneh Bosom Biotechnology: experienced management, access to capital and a clear strategy paves the
August 13 2018
The company says access to capital and a clear strategy will help it succeed
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use